Medicare Enrolled
Dr. Jasmin Javaherian, D.O
Internal Medicine · Encino, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Javaherian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Javaherian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Javaherian
Dr. Jasmin Javaherian is an internal medicine specialist in Encino, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Javaherian performed 2,923 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Javaherian received a total of $489,527 from 81 pharmaceutical and/or device companies across 3535 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Javaherian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in CA
$489,527 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,923
Medicare services
Top 11% in CA for internal medicine
Not available
Unique patients (not deduplicated)
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,415 | $106 | $188 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
586 | $1 | $20 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
349 | $12 | $51 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
151 | $74 | $146 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
130 | $3 | $10 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
90 | $56 | $105 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
69 | $41 | $65 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 50 | $20 | $70 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
50 | $33 | $45 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
17 | $12 | $50 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $50 | $80 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$489,527
Total received (2018-2024)
Avg $69,932/year across 7 years
Top 0% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
3,535
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,098
2023
$30,150
2022
$61,527
2021
$53,874
2020
$17,717
2019
$114,578
2018
$186,583
Payments by company (2024)
Amgen Inc.
$14,568
ABBVIE INC.
$1,625
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,167
Radius Health, Inc.
$835
Regeneron Healthcare Solutions, Inc.
$650
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$558
AstraZeneca Pharmaceuticals LP
$522
Mylan Specialty L.P.
$522
Phathom Pharmaceuticals, Inc.
$482
Mannkind Corporation
$457
Otsuka America Pharmaceutical, Inc.
$407
Xeris Pharmaceuticals, Inc.
$393
Neurocrine Biosciences, Inc.
$344
Teva Pharmaceuticals USA, Inc.
$275
Azurity Pharmaceuticals, Inc.
$246
Esperion Therapeutics, Inc.
$242
GENZYME CORPORATION
$239
Lilly USA, LLC
$237
LEO Pharma Inc.
$228
Almatica Pharma LLC
$212
Novo Nordisk Inc
$204
Optinose US, Inc.
$168
Kowa Pharmaceuticals America, Inc.
$149
Sumitomo Pharma America, Inc.
$140
Bayer Healthcare Pharmaceuticals Inc.
$89
SCILEX PHARMACEUTICALS INC.
$61
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Valinor Pharma, LLC
$37
Top 3 companies account for 69.2% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$117,959
Amarin Pharma Inc.
$73,956
Janssen Pharmaceuticals, Inc
$57,889
Esperion Therapeutics, Inc.
$51,219
Amgen Inc.
$44,545
Regeneron Healthcare Solutions, Inc.
$23,523
Mannkind Corporation
$21,187
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15,785
Boehringer Ingelheim Pharmaceuticals, Inc.
$14,568
MannKind Corporation
$9,670
US WorldMeds, LLC
$7,831
Lilly USA, LLC
$4,400
Kowa Pharmaceuticals America, Inc.
$3,614
ABBVIE INC.
$3,587
Sunovion Pharmaceuticals Inc.
$3,007
Corcept Therapeutics
$2,786
Mylan Specialty L.P.
$2,197
OptiNose US, Inc.
$1,631
AstraZeneca Pharmaceuticals LP
$1,609
Biohaven Pharmaceuticals, Inc.
$1,472
AbbVie Inc.
$1,458
Novartis Pharmaceuticals Corporation
$1,443
KVK-Tech, Inc.
$1,303
Horizon Therapeutics plc
$1,303
Radius Health, Inc.
$1,168
Xeris Pharmaceuticals, Inc.
$1,035
Takeda Pharmaceuticals U.S.A., Inc.
$1,012
Novo Nordisk Inc
$1,009
Gilead Sciences, Inc.
$938
Neurocrine Biosciences, Inc.
$917
ARALEZ PHARMACEUTICALS US INC.
$891
Sumitomo Pharma America, Inc.
$889
Optinose US, Inc.
$882
Teva Pharmaceuticals USA, Inc.
$826
ARBOR PHARMACEUTICALS, INC.
$678
GENZYME CORPORATION
$616
Allergan Inc.
$588
USWM, LLC
$570
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$558
Shire North American Group Inc
$552
UCB, Inc.
$528
Azurity Pharmaceuticals, Inc.
$490
Phathom Pharmaceuticals, Inc.
$482
Almatica Pharma LLC
$463
ITI, Inc.
$449
Bayer HealthCare Pharmaceuticals Inc.
$426
Otsuka America Pharmaceutical, Inc.
$407
Astellas Pharma US Inc
$392
PFIZER INC.
$383
Bayer Healthcare Pharmaceuticals Inc.
$352
Merck Sharp & Dohme Corporation
$333
Arbor Pharmaceuticals, Inc.
$320
Allergan, Inc.
$288
Eisai Inc.
$282
AbbVie, Inc.
$275
LEO Pharma Inc.
$275
Dova Pharmaceuticals
$259
Synergy Pharmaceuticals Inc
$250
Shionogi Inc
$234
Daiichi Sankyo Inc.
$184
BioDelivery Sciences International, Inc.
$171
Medicure Pharma Inc.
$157
Abbott Laboratories
$123
DEXCOM, INC.
$117
Ironwood Pharmaceuticals, Inc
$86
Iroko Pharmaceuticals, LLC
$79
Scilex Pharmaceuticals Inc.
$77
Circassia Pharmaceuticals Inc
$75
SCILEX PHARMACEUTICALS INC.
$61
Medtronic MiniMed, Inc.
$60
Evofem Biosciences, Inc.
$51
RedHill Biopharma Inc.
$47
Merck Sharp & Dohme LLC
$45
Sandoz Inc.
$42
Valinor Pharma, LLC
$37
Sobi, Inc
$33
Horizon Pharma plc
$33
Mycovia Pharmaceuticals, Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$24
Biohaven Pharmaceutical Holding Company Ltd.
$20
EISAI INC.
$20
Top 3 companies account for 51.0% of all-time payments
Associated products mentioned in payments ›
ADBRY · AFREZZA · AIMOVIG · AIRSUPRA · AJOVY · APEXICON E · APTIOM · AUSTEDO · Aimovig · Austedo XR · BELBUCA · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BUNAVAIL 2.1 mg 30-count box · BYDUREON · BYSTOLIC · CAPLYTA · CHANTIX · CREON · Cimzia · Creon · DEXCOM G6 TRANSMITTER · DISEASE STATE · DOPTELET · DUEXIS · DUPIXENT · Dayvigo · Doptelet · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Enbrel · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GEMTESA · GRALISE · GVOKE HYPOPEN · GVOKE PFS · HORIZANT · Horizant · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LIVALO · LONHALA MAGNAIR · LOREEV XR · LUCEMYRA · LYRICA · Linzess · Livalo · Lucemyra · Lucemyra/Lofexidine · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Minimed 670G System · Motegrity · Movantik · Mulpleta · NAMZARIC · NEXLETOL · NEXLIZET · NURTEC ODT · Otezla · Ozempic · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Phexxi · Prolia · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · RELISTOR ORAL · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYMJEPI · Saxenda · Seglentis · TALTZ · TEPEZZA · TERIPARATIDE · TEZSPIRE · TOUJEO · TRADJENTA · TRINTELLIX · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Talicia · Trintellix · Trulance · Tymlos · UBRELVY · UTIBRON · Utibron · VIBERZI · VIIBRYD · VIVLODEX · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Vivjoa · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XIFIXAN · XIIDRA · Xhance · YUPELRI · Yupelri · ZENPEP · ZEPBOUND · ZONTIVITY · ZORYVE · ZTLido · ZYPITAMAG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
4,141
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
ENCINO HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Javaherian is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Javaherian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Javaherian performed 1,415 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Javaherian receive payments from pharmaceutical companies?
Yes. Dr. Javaherian received a total of $489,527 from 81 companies across 3,535 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Javaherian's costs compare to other internal medicine physicians in Encino?
Dr. Javaherian's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Javaherian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Encino
Browse internal medicine physicians in Encino ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology